We are live on
!
Find out more
O
OppenheimerFunds Portfolio holdings
AUM
$80.4B
1-Year Est. Return
15.1%
This Fund
S&P 500
This Quarter
Est. Return
+6.63%
1 Year Est. Return
+15.1%
3 Year Est. Return
+72.05%
5 Year Est. Return
+91.1%
10 Year Est. Return
–
AUM
$82.8B
AUM Growth
+$1.44B
(+1.8%)
Cap. Flow
-$2.02B
Cap. Flow
% of AUM
-2.43%
Top 10 Holdings %
Top 10 Hldgs %
16.17%
Holding
1,933
New
90
Increased
882
Reduced
857
Closed
96
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
eBay
EBAY
|
+$366M |
| 2 |
CarMax
KMX
|
+$273M |
| 3 |
O'Reilly Automotive
ORLY
|
+$240M |
| 4 |
Motorola Solutions
MSI
|
+$212M |
| 5 |
Alibaba
BABA
|
+$201M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nektar Therapeutics
NKTR
|
+$401M |
| 2 |
TechnipFMC
FTI
|
+$399M |
| 3 |
AutoZone
AZO
|
+$327M |
| 4 |
Cisco
CSCO
|
+$232M |
| 5 |
NetEase
NTES
|
+$181M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.41% |
| 2 | Consumer Discretionary | 14.11% |
| 3 | Energy | 13.48% |
| 4 | Healthcare | 12.91% |
| 5 | Technology | 11.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FMBI
1526
DELISTED
First Midwest Bancorp Inc/IL
FMBI
| $486K | ﹤0.01% |
20,253
-748
| -4% | -$17.8K |
|
1527
Gartner
IT
$9.41B
| $485K | ﹤0.01% |
3,939
-144,906
| -97% | -$17.6M |
|
|
AFAM
1528
DELISTED
Almost Family Inc
AFAM
| $485K | ﹤0.01% |
8,754
-7,490
| -46% | -$399K |
|
1529
Old National Bancorp
ONB
$10.1B
| $484K | ﹤0.01% |
27,741
-2,611
| -9% | -$46.9K |
|
1530
Marten Transport
MRTN
$1.33B
| $483K | ﹤0.01% |
35,691
-3,261
| -8% | -$42.7K |
|
|
NTRI
1531
DELISTED
NutriSystem, Inc.
NTRI
| $483K | ﹤0.01% |
9,171
-381,027
| -98% | -$20M |
|
1532
Chord Energy
CHRD
$7.79B
| $482K | ﹤0.01% |
57,256
-17,104
| -23% | -$158K |
|
|
HF
1533
DELISTED
HFF Inc.
HF
| $476K | ﹤0.01% |
9,787
-958
| -9% | -$42.2K |
|
1534
First Bancorp
FBP
$4.4B
| $471K | ﹤0.01% |
92,250
+6,243
| +7% | +$31.1K |
|
|
VAR
1535
DELISTED
Varian Medical Systems, Inc.
VAR
| $471K | ﹤0.01% |
4,235
+234
| +6% | +$25.2K |
|
1536
Hope Bancorp
HOPE
$1.72B
| $470K | ﹤0.01% |
25,728
-1,516
| -6% | -$27.5K |
|
1537
Jack Henry & Associates
JKHY
$10.7B
| $467K | ﹤0.01% |
3,990
+297
| +8% | +$33.2K |
|
1538
SEI Investments
SEIC
$11.9B
| $467K | ﹤0.01% |
6,494
-400
| -6% | -$26.8K |
|
1539
LivaNova
LIVN
$4.3B
| $466K | ﹤0.01% |
5,836
+168
| +3% | +$13.3K |
|
1540
Ardmore Shipping
ASC
$678M
| $465K | ﹤0.01% |
58,133
-1,493
| -3% | -$12.5K |
|
|
TSG
1541
DELISTED
The Stars Group Inc.
TSG
| $465K | ﹤0.01% |
19,951
-3,946
| -17% | -$85.9K |
|
|
SRCI
1542
DELISTED
SRC Energy Inc
SRCI
| $461K | ﹤0.01% |
54,041
+34,850
| +182% | +$307K |
|
|
ACET
1543
DELISTED
Aceto Corp
ACET
| $461K | ﹤0.01% |
44,623
+3,147
| +8% | +$33.1K |
|
1544
Omnicell
OMCL
$1.86B
| $460K | ﹤0.01% |
9,487
-343
| -3% | -$17.3K |
|
1545
Universal Electronics
UEIC
$57.2M
| $460K | ﹤0.01% |
9,747
+1,703
| +21% | +$94.4K |
|
|
NPKI
1546
NPK International
NPKI
$1.21B
| $460K | ﹤0.01% |
53,408
+9,367
| +21% | +$84.8K |
|
|
CKH
1547
DELISTED
Seacor Holdings Inc.
CKH
| $460K | ﹤0.01% |
9,959
-2,698
| -21% | -$124K |
|
1548
H&R Block
HRB
$5.18B
| $458K | ﹤0.01% |
17,461
+1,487
| +9% | +$38.6K |
|
1549
Equity Residential
EQR
$25.4B
| $455K | ﹤0.01% |
7,142
+2,227
| +45% | +$149K |
|
|
LDL
1550
DELISTED
Lydall, Inc.
LDL
| $455K | ﹤0.01% |
8,967
+400
| +5% | +$21.9K |
|
Similar funds
TA
TCIM
HFS
SBAM
BB
SA
WF
BCPEM
OppenheimerFunds's Q4 2017 Portfolio in Review
As of Q4 2017, OppenheimerFunds held 1,933 positions worth $82.8B, up 1.8% from $81.4B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
OppenheimerFunds's Q4 2017 filing shows 90 new, 882 increased, 857 reduced and 96 closed positions. Its largest new stake was Nebius Group N.V.: 5,110,710 shares worth $167M. The largest sale was Nektar Therapeutics, an estimated $401M.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Energy.
- OppenheimerFunds's largest Q4 2017 buy was Nebius Group N.V.: 5,110,710 shares worth $167M.
- OppenheimerFunds added most to eBay in Q4 2017, an estimated $366M increase.
- OppenheimerFunds's biggest Q4 2017 reduction was Nektar Therapeutics, cutting an estimated $401M.
- OppenheimerFunds fully exited NetEase in Q4 2017, selling an estimated $181M.
- OppenheimerFunds's ten largest holdings make up 16% of its $82.8B portfolio in Q4 2017.
- OppenheimerFunds opened 90 new positions and closed 96 in Q4 2017.
- OppenheimerFunds's portfolio value rose 1.8% quarter-over-quarter to $82.8B.
Based on OppenheimerFunds's 13F filing for Q4 2017, filed 12 Feb 2018.